标题
Anti-TNF Therapy in Crohn’s Disease
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 19, Issue 8, Pages 2244
出版商
MDPI AG
发表日期
2018-08-01
DOI
10.3390/ijms19082244
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- ACG Clinical Guideline: Management of Crohn’s Disease in Adults
- (2018) Gary R Lichtenstein et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Molecular mechanisms of action of anti-TNF-α agents – Comparison among therapeutic TNF-α antagonists
- (2018) Hiroki Mitoma et al. CYTOKINE
- Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, and Corticosteroid-Free Remission in Patients With Active Luminal Crohn’s Disease
- (2018) Geert D’Haens et al. GASTROENTEROLOGY
- Developing a core outcome set for fistulising perianal Crohn’s disease
- (2018) Kapil Sahnan et al. GUT
- American Gastroenterological Association Institute Technical Review on the Role of Therapeutic Drug Monitoring in the Management of Inflammatory Bowel Diseases
- (2017) Niels Vande Casteele et al. GASTROENTEROLOGY
- American Gastroenterological Association Institute Guideline on Therapeutic Drug Monitoring in Inflammatory Bowel Disease
- (2017) Joseph D. Feuerstein et al. GASTROENTEROLOGY
- Crohn's disease
- (2017) Joana Torres et al. LANCET
- Update on anti-tumor necrosis factor agents and other new drugs for inflammatory bowel disease
- (2017) Benjamin L Cohen et al. BMJ-British Medical Journal
- Update on anti-tumor necrosis factor agents and other new drugs for inflammatory bowel disease
- (2017) Benjamin L Cohen et al. BMJ-British Medical Journal
- Anti-TNF-α therapies for the treatment of Crohn’s disease: the past, present and future
- (2016) Marc Berns et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Biosimilar therapies in inflammatory bowel disease: should we care about patient profile?
- (2016) Gionata Fiorino et al. Expert Review of Clinical Immunology
- ECCO Position Statement on the Use of Biosimilars for Inflammatory Bowel Disease—An Update
- (2016) Silvio Danese et al. Journal of Crohns & Colitis
- 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1: Diagnosis and Medical Management
- (2016) Fernando Gomollón et al. Journal of Crohns & Colitis
- Biosimilars in IBD: from theory to practice
- (2016) Silvio Danese et al. Nature Reviews Gastroenterology & Hepatology
- Review article: pharmacological aspects of anti-TNF biosimilars in inflammatory bowel diseases
- (2015) K. Papamichael et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Systematic review with meta-analysis: the efficacy of a second anti-TNF in patients with inflammatory bowel disease whose previous anti-TNF treatment has failed
- (2015) J. P. Gisbert et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Trough Concentrations of Infliximab Guide Dosing for Patients With Inflammatory Bowel Disease
- (2015) Niels Vande Casteele et al. GASTROENTEROLOGY
- Systematic Review of Effects of Withdrawal of Immunomodulators or Biologic Agents From Patients With Inflammatory Bowel Disease
- (2015) Joana Torres et al. GASTROENTEROLOGY
- The association of tissue anti-TNF drug levels with serological and endoscopic disease activity in inflammatory bowel disease: the ATLAS study
- (2015) Andres J Yarur et al. GUT
- Therapeutic Drug Monitoring of Anti-tumor Necrosis Factor Agents in Patients with Inflammatory Bowel Diseases
- (2015) Andres J. Yarur et al. INFLAMMATORY BOWEL DISEASES
- Pharmacokinetics of anti-TNF monoclonal antibodies in inflammatory bowel disease: Adding value to current practice
- (2015) Niels Vande Casteele et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Cancers Complicating Inflammatory Bowel Disease
- (2015) Laurent Beaugerie et al. NEW ENGLAND JOURNAL OF MEDICINE
- Withdrawal of anti-tumour necrosis factor α therapy in inflammatory bowel disease
- (2015) Konstantinos Papamichael WORLD JOURNAL OF GASTROENTEROLOGY
- Systematic review with network meta-analysis: the efficacy of anti-TNF agents for the treatment of Crohn's disease
- (2014) R. W. Stidham et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Safety considerations when using anti-TNFα therapy to treat Crohn’s disease
- (2014) Cristiano Pagnini et al. Expert Opinion On Drug Safety
- Miscellaneous Adverse Events with Biologic Agents (Excludes Infection and Malignancy)
- (2014) Joseph D. Feuerstein et al. GASTROENTEROLOGY CLINICS OF NORTH AMERICA
- Association Between Tumor Necrosis Factor-α Antagonists and Risk of Cancer in Patients With Inflammatory Bowel Disease
- (2014) Nynne Nyboe Andersen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Outcome of elective withdrawal of anti-tumour necrosis factor-α therapy in patients with Crohn's disease in established remission
- (2014) A.J. Brooks et al. Journal of Crohns & Colitis
- Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease
- (2014) J.F. Rahier et al. Journal of Crohns & Colitis
- Mucosal Healing Did Not Predict Sustained Clinical Remission in Patients with IBD after Discontinuation of One-Year Infliximab Therapy
- (2014) Cong Dai et al. PLoS One
- Pre-existing IgG antibodies cross-reacting with the Fab region of infliximab predict efficacy and safety of infliximab therapy in inflammatory bowel disease
- (2013) C. Steenholdt et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Antibody Response to Infliximab and its Impact on Pharmacokinetics can be Transient
- (2013) Niels Vande Casteele et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Adalimumab and Infliximab Are Equally Effective for Crohn's Disease in Patients Not Previously Treated With Anti–Tumor Necrosis Factor-α Agents
- (2013) Christine Kestens et al. Clinical Gastroenterology and Hepatology
- Comparative Effectiveness of Infliximab and Adalimumab for Crohn's Disease
- (2013) Mark T. Osterman et al. Clinical Gastroenterology and Hepatology
- Inflammatory Bowel Disease Is Associated With an Increased Risk of Melanoma: A Systematic Review and Meta-analysis
- (2013) Siddharth Singh et al. Clinical Gastroenterology and Hepatology
- Anti-TNF Antibodies in Inflammatory Bowel Disease: Do We Finally Know How it Works?
- (2013) Angelos Oikonomopoulos et al. CURRENT DRUG TARGETS
- Top-Down or Step-Up Treatment in Crohn's Disease?
- (2013) Gerhard Rogler DIGESTIVE DISEASES
- Targeting TNF-α for the treatment of inflammatory bowel disease
- (2013) Thomas Billiet et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Drug safety evaluation of certolizumab pegol
- (2013) Marc Ferrante et al. Expert Opinion On Drug Safety
- American Gastroenterological Association Institute Technical Review on the Use of Thiopurines, Methotrexate, and Anti–TNF-α Biologic Drugs for the Induction and Maintenance of Remission in Inflammatory Crohn's Disease
- (2013) Themistocles Dassopoulos et al. GASTROENTEROLOGY
- Step Up Versus Early Biologic Therapy for Crohnʼs Disease in Clinical Practice
- (2013) Leyla J. Ghazi et al. INFLAMMATORY BOWEL DISEASES
- Antibodies to Infliximab and Risk of Infusion Reactions in Patients With Inflammatory Bowel Disease
- (2013) Sorcha O’Meara et al. INFLAMMATORY BOWEL DISEASES
- Comparative Effectiveness of Anti-TNF Agents for Crohn’s Disease in a Tertiary Referral IBD Practice
- (2012) Seema A. Patil et al. DIGESTIVE DISEASES AND SCIENCES
- Risk of Melanoma and Nonmelanoma Skin Cancer Among Patients With Inflammatory Bowel Disease
- (2012) Millie D. Long et al. GASTROENTEROLOGY
- Adalimumab Induces and Maintains Mucosal Healing in Patients With Crohn's Disease: Data From the EXTEND Trial
- (2012) Paul Rutgeerts et al. GASTROENTEROLOGY
- Long-term MRI-guided combined anti-TNF-α and thiopurine therapy for crohnʼs perianal fistulas
- (2012) Phil Tozer et al. INFLAMMATORY BOWEL DISEASES
- Outcome after discontinuation of infliximab in patients with inflammatory bowel disease in clinical remission: an observational Danish single center study
- (2012) Casper Steenholdt et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Incidence of acute severe infusion reactions to infliximab depends on definition used rather than assay
- (2011) N. Vande Casteele et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Loss of Response and Need for Adalimumab Dose Intensification in Crohn's Disease: A Systematic Review
- (2011) Vincent Billioud et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Efficacy of Biological Therapies in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis
- (2011) Alexander C Ford et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Certolizumab Pegol for Active Crohn's Disease: A Placebo-Controlled, Randomized Trial
- (2011) William J. Sandborn et al. Clinical Gastroenterology and Hepatology
- Maintenance of Remission Among Patients With Crohn's Disease on Antimetabolite Therapy After Infliximab Therapy Is Stopped
- (2011) Edouard Louis et al. GASTROENTEROLOGY
- Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review
- (2011) Natalie A. Molodecky et al. GASTROENTEROLOGY
- Therapeutic Drug Monitoring of Biologics for Inflammatory Bowel Disease
- (2011) Jean-Frédéric Colombel et al. INFLAMMATORY BOWEL DISEASES
- Maintenance of clinical benefit in Crohn’s disease patients after discontinuation of infliximab: long-term follow-up of a single centre cohort
- (2010) A. W. G. Waugh et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Randomised clinical trial: certolizumab pegol for fistulas in Crohn’s disease - subgroup results from a placebo-controlled study
- (2010) S. Schreiber et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD With the European Crohn's and Colitis Organisation: Pregnancy and Pediatrics
- (2010) Uma Mahadevan et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Pharmacokinetics and Pharmacodynamics of Monoclonal Antibodies
- (2010) Diane R. Mould et al. BIODRUGS
- Certolizumab Pegol in Patients With Moderate to Severe Crohn's Disease and Secondary Failure to Infliximab
- (2010) William J. Sandborn et al. Clinical Gastroenterology and Hepatology
- Continuous Therapy With Certolizumab Pegol Maintains Remission of Patients With Crohn's Disease for up to 18 Months
- (2010) Gary R. Lichtenstein et al. Clinical Gastroenterology and Hepatology
- A decade of infliximab: The Austrian evidence based consensus on the safe use of infliximab in inflammatory bowel disease
- (2010) W. Miehsler et al. Journal of Crohns & Colitis
- Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
- (2010) Jean Frédéric Colombel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Transmembrane TNF- : structure, function and interaction with anti-TNF agents
- (2010) T. Horiuchi et al. RHEUMATOLOGY
- Loss of Response and Requirement of Infliximab Dose Intensification in Crohn's Disease: A Review
- (2009) Javier P Gisbert et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Serum sickness, encephalitis and other complications of anti-cytokine therapy
- (2009) Séverine Vermeire et al. BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
- Adalimumab for the treatment of fistulas in patients with Crohn's disease
- (2009) J-F Colombel et al. GUT
- Adalimumab safety in global clinical trials of patients with Crohnʼs disease
- (2009) Jean-Frédéric Colombel et al. INFLAMMATORY BOWEL DISEASES
- Placental Transport of Immunoglobulins: A Clinical Review for Gastroenterologists Who Prescribe Therapeutic Monoclonal Antibodies to Women During Conception and Pregnancy
- (2008) Sunanda V Kane et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Efficacy and Safety of Tumor Necrosis Factor Antagonists in Crohn's Disease: Meta-Analysis of Placebo-Controlled Trials
- (2008) Laurent Peyrin–Biroulet et al. Clinical Gastroenterology and Hepatology
- Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single-centre cohort study
- (2008) H Fidder et al. GUT
- Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease: results from a single-centre cohort
- (2008) F Schnitzler et al. GUT
- Is the efficacy of successful infliximab induction therapy maintained for one year lasting without retreatment in different behavior types of Crohn's disease?
- (2008) T. Molnár et al. Journal of Crohns & Colitis
- Role of cytokines in inflammatory bowel disease
- (2008) Fausto Sanchez-Muñoz et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Tumor necrosis factor antagonist mechanisms of action: A comprehensive review
- (2007) Daniel Tracey et al. PHARMACOLOGY & THERAPEUTICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started